NCT01299467 - A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen Challenge | Biotech Hunter

Timeline

Start Date

February 28, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions

Asthma

Interventions

DRUG

Active (PF-03526299)

Capsules for inhalation, 1.396 mg twice a day for up to 13 days. Last dose given 0.5 hrs before allergen challenge

DRUG

Active (PF-03526299)

Capsules for inhalation, 1.396 mg twice a day for up to 12 days. Last dose given 8 hrs before allergen challenge

DRUG

Placebo

Capsules for inhalation, Placebo, twice a day for up to 13 days. Last dose given 0.5 hrs before allergen challenge

DRUG

Active (PF-03526299)

Capsules for inhalation, 4.188 mg twice a day for up to 13 days. Last dose given 0.5 hrs before allergen challenge

DRUG

Active (PF-03526299)

Capsules for inhalation, 4.188 mg twice a day for up to 12 days. Last dose given 8hrs before allergen challenge

DRUG

Placebo

Capsules for inhalation, Placebo, twice a day for up to 13 days. Last dose given 0.5 hrs before allergen challenge